Work

Abstract 6763: KBD111 is a highly selective, long-acting and brain-penetrant PARP1 inhibitor

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-6763

Authors: Jing Zhang, Yang Chen, Yonggang Wei, Fei Ye, Zhiyong Li, Xiaoke Liu, Jiannan Cui

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148664884

Cites:

Cited by: 1

Related to: